Clinical Trial Update: Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OA [Phase 4]

View source ↗

Summary

This trial update reports the completion of a Phase 4 study evaluating autologous plasma rich in growth factors (PRGF) for symptomatic knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Autologous Plasma Rich in Growth Factors (PRGF) (platelet-rich plasma)

Snippet

Sponsor: Biotechnology Institute IMASD | Conditions: Joint Disease | Phase 4 | Status: COMPLETED